User profiles for A. Whitney Brown

A. Whitney Brown, Anne Whitney Brown, Anne W Brown

Inova Fairfax Hospital
Verified email at inova.org
Cited by 1355

Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease

…, Y Belessis, A Whitney Brown… - Clinical infectious …, 2023 - academic.oup.com
Background Nontuberculous Mycobacterium infections, particularly Mycobacterium abscessus,
are increasingly common among patients with cystic fibrosis and chronic bronchiectatic …

The value and application of the 6-minute-walk test in idiopathic pulmonary fibrosis

AW Brown, SD Nathan - Annals of the American Thoracic Society, 2018 - atsjournals.org
The 6-minute-walk test is a commonly used assessment of performance ability in a variety of
cardiopulmonary diseases. It provides important functional information that is not captured …

High-flow nasal cannula therapy in COVID-19: using the ROX index to predict success

A Chandel, S Patolia, AW Brown, AC Collins… - Respiratory …, 2021 - rc.rcjournal.com
BACKGROUND: Optimal timing of mechanical ventilation in COVID-19 is uncertain. We sought
to evaluate outcomes of delayed intubation and examine the ROX index (ie, [ S pO 2 /F IO …

[HTML][HTML] Ex vivo lung perfusion: a review of current and future application in lung transplantation

K Ahmad, JL Pluhacek, AW Brown - Pulmonary Therapy, 2022 - Springer
The number of waitlisted lung transplant candidates exceeds the availability of donor organs.
Barriers to utilization of donor lungs include suboptimal lung allograft function, long …

Effect of recombinant human pentraxin 2 vs placebo on change in forced vital capacity in patients with idiopathic pulmonary fibrosis: a randomized clinical trial

G Raghu, B Van Den Blink, MJ Hamblin, AW Brown… - Jama, 2018 - jamanetwork.com
Importance Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with
poor prognosis. Approved therapies do not halt disease progression. Objective To determine …

[HTML][HTML] Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure

CS King, D Sahjwani, AW Brown, S Feroz, P Cameron… - Plos one, 2020 - journals.plos.org
Purpose The outcomes of patients requiring invasive mechanical ventilation for COVID-19
remain poorly defined. We sought to determine clinical characteristics and outcomes of …

Critical care of the adult patient with cystic fibrosis

CS King, AW Brown, S Aryal, K Ahmad, S Donaldson - Chest, 2019 - Elsevier
… Optimal CF care requires a multidisciplinary team at a center experienced in caring for this …
to care at an accredited center may not always be immediately available. An analysis of 1,249 …

Fostamatinib for the treatment of hospitalized adults with coronavirus disease 2019: a randomized trial

…, R Reger, J Cohen, K Ahmad, AW Brown… - Clinical Infectious …, 2022 - academic.oup.com
… in patients with a baseline ordinal score of 5, we performed a subgroup analysis in those
enrolled with a baseline ordinal score of 6 or 7, which suggested a trend toward reduced …

Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study

…, B van den Blink, MJ Hamblin, AW Brown… - The Lancet …, 2019 - thelancet.com
… 2 study were eligible to participate in an open-label extension study to assess long-term
safety and efficacy of PRM-151. Here we present an analysis of the safety and efficacy with up to …

[HTML][HTML] … evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension …

G Raghu, MJ Hamblin, AW Brown, JA Golden… - Respiratory …, 2022 - Springer
Background Recombinant human pentraxin-2 (rhPTX-2) significantly decreased decline in
percent predicted forced vital capacity (FVC) and stabilized 6-min walk distance (6MWD) in …